New Developments in Retinal Pharmacotherapy

Uveitis Clinical Trials: A Review of FDA-approved Therapies

Uveitis Clinical Trials: A Review of FDA-approved Therapies

What I'm going to do is present to you FDA approved therapies for the trea…

Expiration Date: 12/30/2014

Max Credits: 0

View Activity

Managing Uveitis and Postoperative Inflammation: A Review of Local Therapies and MOA

Managing Uveitis and Postoperative Inflammation: A Review of Local Therapies and MOA

So we're talking about post-operative inflammation, obviously it effects a…

Expiration Date: 12/30/2014

Max Credits: 0

View Activity

Dosing Issues in Retinal Vein Occlusion

Dosing Issues in Retinal Vein Occlusion

I'm going to go over 2 aspects of treatment of Retinal Vein Occlusion. Fir…

Expiration Date: 12/26/2014

Max Credits: 0

View Activity

Combination Therapy in the Management of RVO

Combination Therapy in the Management of RVO

So I think you've learned from listening and watching these cases that one…

Expiration Date: 12/26/2014

Max Credits: 0

View Activity

Examining the Pathophysiology of Retinal Vein Occlusion and the Potential Role of Anti-VEGF Agents

Examining the Pathophysiology of Retinal Vein Occlusion and the Potential Role of Anti-VEGF Agents

As we all know, Retinal Vein Occlusion is the second most common retinal v…

Expiration Date: 12/26/2014

Max Credits: 0

View Activity

Case Presentation: Dosing and Administration of Anti-VEGF Therapies for RVO

Case Presentation: Dosing and Administration of Anti-VEGF Therapies for RVO

We have a lot of clinical trial data to guide us, but what are we actually…

Expiration Date: 12/26/2014

Max Credits: 0

View Activity

Contemporary Management of Diseases of the Vitreomacular Interface

Contemporary Management of Diseases of the Vitreomacular Interface

The topic is Ocriplasmin in Clinical Practice, and we now have experience …

Expiration Date: 12/17/2014

Max Credits: 0

View Activity

Potential Role of Aflibercept as the Next VEGF Antagonist in the Management of Diabetic Macular Edema

Potential Role of Aflibercept as the Next VEGF Antagonist in the Management of Diabetic Macular Edema

Several treatment strategies have been used to halt or decelerate disease …

Expiration Date: 10/31/2014

Max Credits: 0

View Activity

Combination Anti-VEGF and Dexamethasone Therapy for Macular Edema Associated with Retinal Venous Occlusions

Combination Anti-VEGF and Dexamethasone Therapy for Macular Edema Associated with Retinal Venous Occlusions

Retinal vein occlusion (RVO) is the second most common type of retinal vas…

Expiration Date: 10/31/2014

Max Credits: 0

View Activity

Ranibizumab in the Management of Diabetic Macular Edema: Where Do We Stand in 2013?

Ranibizumab in the Management of Diabetic Macular Edema: Where Do We Stand in 2013?

Diabetic macular edema (DME) is a primary cause of vision loss in the work…

Expiration Date: 10/31/2014

Max Credits: 0

View Activity